Thursday - October 23, 2025
IMF's Asian Myeloma Network Publishes Randomized Phase III AMN003 Study Results
October 07, 2025
NORTH HOLLYWOOD, California, Oct. 7 (TNSjou) -- The International Myeloma Foundation issued the following news:

* * *

IMF's Asian Myeloma Network Publishes Randomized Phase III AMN003 Study Results

Study Finds Affordable Three-Drug Combination Improves Outcomes in Relapsed/Refractory Multiple Myeloma

*

A new phase III study by the Asian Myeloma Network (AMN) found that adding the affordable chemotherapy drug Cytoxan(R) (cyclop . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products